e-learning
resources
Munich 2006
Sunday 03.09.2006
Lung vascular and parenchymal remodeling
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension
R. E. Morty, B. Nejman, F. Kouri, A. Zakrzewicz, M. Hecker, R. Sandu, R. Dumitrascu, R. T. Schermuly, W. Seeger, O. Eickelberg (Giessen, Germany)
Source:
Annual Congress 2006 - Lung vascular and parenchymal remodeling
Session:
Lung vascular and parenchymal remodeling
Session type:
Oral Presentation
Number:
936
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. E. Morty, B. Nejman, F. Kouri, A. Zakrzewicz, M. Hecker, R. Sandu, R. Dumitrascu, R. T. Schermuly, W. Seeger, O. Eickelberg (Giessen, Germany). Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension. Eur Respir J 2006; 28: Suppl. 50, 936
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Source: Eur Respir J 2015; 45: 1066-1080
Year: 2015
TGF-β and BMP signal transduction pathways in pulmonary hypertension
Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Year: 2003
TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Endothelial control of BMPR2 signalling in experimental shunt-induced pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
The dual role of apoptosis in pulmonary hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
The modulatory effects of Nrf2 activators in a pulmonary arterial hypertension model
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats
Source: Eur Respir J 2011; 37: 813-822
Year: 2011
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension},
Source: Eur Respir J 2012; 40: 895-904
Year: 2012
Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021
Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1137-1149
Year: 2016
Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Beyond a single pathway: combination therapy in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 408-417
Year: 2016
ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept